Merck Healthcare Kgaa, Darmstadt, Germany, An Affiliate Of Merck Kgaa, Darmstadt, Germany

This study tests a drug called pimicotinib in 20 Japanese adults with tenosynovial giant cell tumor (TGCT), a rare, non-cancerous tumor that grows around joints and can cause pain and stiffness. The goal is to see if the drug can shrink the tumor and improve symptoms. Participant…

This study tests a new combination of fertility hormones (follitropin alfa and lutropin alfa) against a standard treatment (hMG) in Japanese women with low LH and FSH who are undergoing IVF. The goal is to see if the new drug helps produce more eggs for retrieval. About 333 women…

This study tests a new oral form of cladribine to see if it improves daily activities and muscle strength in people with generalized myasthenia gravis, a condition causing muscle weakness. About 264 adults will receive either the drug or a placebo, and researchers will track chan…

This early-stage study is testing a new drug, M5542, in healthy adults to see if it is safe and how the body processes it. About 49 participants will receive either a single dose of M5542 or a placebo by injection. The goal is to check for side effects and measure drug levels in …